{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:13:36Z","timestamp":1781900016428,"version":"3.54.5"},"reference-count":79,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Human post-partum tissue mesenchymal stromal cells (hPPT-MSCs) are widely used in research to investigate their differentiation capabilities and therapeutic effects as potential agents in cell-based therapy. This is ascribed to the advantages offered by the use of MSCs isolated from hPPT over other MSC sources. A paradigm shift in related research is evident that focuses on the secretome of the human MSCs (hMSCs), as therapeutic effects of hMSCs are attributed more so to their secreted growth factors, cytokines and chemokines and to the extracellular vesicles (EVs), all of which are components of the hMSC secretome. Positive therapeutic effects of the hPPT-MSC secretome have been demonstrated in diseases related to skin, kidney, heart, nervous system, cartilage and bones, that have aided fast recovery by replacing damaged, non-functional tissues, via differentiating and regenerating cells. Although certain limitations such as short half -life of the secretome components and irregular secreting patterns exist in secretome therapy, these issues are successfully addressed with the use of cutting-edge technologies such as genome editing and recombinant cytokine treatment. If the current limitations can be successfully overcome, the hPPT-MSC secretome including its EVs may be developed into a cost-effective therapeutic agent amenable to be used against a wide range of diseases\/disorders.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1450_18","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T14:00:10Z","timestamp":1640008810000},"page":"541-552","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic uses of post-partum tissue-derived mesenchymal stromal cell secretome"],"prefix":"10.25259","volume":"152","author":[{"given":"Vindya Lankika","family":"Udalamaththa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athula","family":"Kaluarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumedha","family":"Wijeratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi Vidya","family":"Udagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-4-20241212","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.CIR.0000057525.13182.24","article-title":"Stem cell therapy in perspective","volume":"107","author":"Strauer","year":"2003","journal-title":"Circulation"},{"key":"R2-4-20241212","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1479-5876-11-196","article-title":"Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism","volume":"11","author":"Lv","year":"2013","journal-title":"J Transl Med"},{"key":"R3-4-20241212","first-page":"141","article-title":"Human umbilical cord mesenchymal stem cells in the treatment of duchenne muscular dystrophy: Safety and feasibility study in India","volume":"10","author":"Rajput","year":"2015","journal-title":"J Stem Cells"},{"key":"R4-4-20241212","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical Trials with mesenchymal stem cells: An Update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transplant"},{"key":"R5-4-20241212","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)00005-5","article-title":"The tumorigenicity of human embryonic stem cells","volume":"100","author":"Blum","year":"2008","journal-title":"Adv Cancer Res"},{"key":"R6-4-20241212","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/labinvest.2017.81","article-title":"A pathologist's perspective on induced pluripotent stem cells","volume":"97","author":"Watanabe","year":"2017","journal-title":"Lab Invest"},{"key":"R7-4-20241212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13287-016-0366-4","article-title":"Potential role of herbal remedies in stem cell therapy: Proliferation and differentiation of human mesenchymal stromal cells","volume":"7","author":"Udalamaththa","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"R8-4-20241212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Commun Signal"},{"key":"R9-4-20241212","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.3390\/ijms140611692","article-title":"Wharton's jelly-derived mesenchymal stem cells: Phenotypic characterization and optimizing their therapeutic potential for clinical applications","volume":"14","author":"Kim","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R11-4-20241212","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.3390\/ijms140917986","article-title":"Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy","volume":"14","author":"Jin","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R12-4-20241212","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.stem.2010.09.001","article-title":"Expansion of human cord blood hematopoietic stem cells for transplantation","volume":"7","author":"Chou","year":"2010","journal-title":"Cell Stem Cell"},{"key":"R13-4-20241212","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","article-title":"Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood","volume":"22","author":"Bieback","year":"2004","journal-title":"Stem Cells"},{"key":"R14-4-20241212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","article-title":"Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue","volume":"37","author":"Heo","year":"2016","journal-title":"Int J Mol Med"},{"key":"R15-4-20241212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/scrt66","article-title":"Amnion-derived stem cells: In quest of clinical applications","volume":"2","author":"Miki","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"R16-4-20241212","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/ten.2006.0313","article-title":"Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue","volume":"13","author":"Wolbank","year":"2007","journal-title":"Tissue Eng"},{"key":"R17-4-20241212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clim.2010.01.015","article-title":"Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism","volume":"135","author":"Chen","year":"2010","journal-title":"Clin Immunol"},{"key":"R18-4-20241212","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2008.02891.x","article-title":"The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro","volume":"126","author":"Wang","year":"2009","journal-title":"Immunology"},{"key":"R19-4-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2014.10.007","article-title":"Stem cells as drug delivery methods: Application of stem cell secretome for regeneration","volume":"82-83","author":"Tran","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"R20-4-20241212","doi-asserted-by":"crossref","first-page":"6901286","DOI":"10.1155\/2016\/6901286","article-title":"Umbilical cord as prospective source for mesenchymal stem cell-based therapy","volume":"2016","author":"Arutyunyan","year":"2016","journal-title":"Stem Cells Int"},{"key":"R21-4-20241212","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell Stem Cell"},{"key":"R22-4-20241212","doi-asserted-by":"crossref","first-page":"e113769","DOI":"10.1371\/journal.pone.0113769","article-title":"MSCs conditioned media and umbilical cord blood plasma metabolomics and composition","volume":"9","author":"Pereira","year":"2014","journal-title":"PLoS One"},{"key":"R23-4-20241212","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2009.10.058","article-title":"Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair","volume":"390","author":"Zisa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-4-20241212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ten.teb.2011.0488","article-title":"Therapeutic applications of mesenchymal stromal cells: Paracrine effects and potential improvements","volume":"18","author":"Doorn","year":"2012","journal-title":"Tissue Eng Part B Rev"},{"key":"R25-4-20241212","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","article-title":"Mesenchymal stem cell-derived microvesicles protect against acute tubular injury","volume":"20","author":"Bruno","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R26-4-20241212","doi-asserted-by":"crossref","first-page":"29828","DOI":"10.3402\/jev.v5.29828","article-title":"MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA","volume":"5","author":"Lai","year":"2016","journal-title":"J Extracell Vesicles"},{"key":"R27-4-20241212","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13273-017-0014-9","article-title":"Molecular signatures of secretomes from mesenchymal stem cellsmesenchymal stemromal cells: Therapeutic benefits","volume":"13","author":"Suh","year":"2017","journal-title":"Mol Cel Toxicol"},{"key":"R28-4-20241212","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/stem.1771","article-title":"HucMSC-exosome mediated-wnt4 signaling is required for cutaneous wound healing","volume":"33","author":"Zhang","year":"2015","journal-title":"Stem Cells"},{"key":"R29-4-20241212","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"R30-4-20241212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1566523217666170412110724","article-title":"Mesenchymal stem cell-derived extracellular vesicles for renal repair","volume":"17","author":"Nargesi","year":"2017","journal-title":"Curr Gene Ther"},{"key":"R31-4-20241212","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1089\/scd.2016.0048","article-title":"Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: A proteomic analysis","volume":"25","author":"Pires","year":"2016","journal-title":"Stem Cells Dev"},{"key":"R32-4-20241212","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1089\/scd.2013.0016","article-title":"Mesenchymal stromal cell characteristics vary depending on their origin","volume":"22","author":"Wegmeyer","year":"2013","journal-title":"Stem Cells Dev"},{"key":"R33-4-20241212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/scrt442","article-title":"Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly","volume":"5","author":"Amable","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"R34-4-20241212","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/scd.2014.0184","article-title":"Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway","volume":"24","author":"Kuchroo","year":"2015","journal-title":"Stem Cells Dev"},{"key":"R35-4-20241212","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cbin.10056","article-title":"Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow","volume":"37","author":"Balasubramanian","year":"2013","journal-title":"Cell Biol Int"},{"key":"R36-4-20241212","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbmt.2007.08.048","article-title":"Umbilical cord mesenchymal stem cells: Adjuvants for human cell transplantation","volume":"13","author":"Friedman","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R37-4-20241212","doi-asserted-by":"crossref","first-page":"438352","DOI":"10.1155\/2014\/438352","article-title":"The Secretome of Bone marrow and Wharton jelly derived mesenchymal stem cells induces differentiation and neurite outgrowth in sh-sy5y cells","volume":"2014","author":"Pires","year":"2014","journal-title":"Stem Cells Int"},{"key":"R38-4-20241212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1008-1275(08)60045-0","article-title":"Therapeutic potential of stem cells in skin repair and regeneration","volume":"11","author":"Zhang","year":"2008","journal-title":"Chin J Traumatol"},{"key":"R39-4-20241212","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11892-004-0049-x","article-title":"Reducing the incidence of foot ulceration and amputation in diabetes","volume":"4","author":"Bartus","year":"2004","journal-title":"Curr Diab Rep"},{"key":"R40-4-20241212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13054-015-0961-2","article-title":"Burn wound healing and treatment: Review and advancements","volume":"19","author":"Rowan","year":"2015","journal-title":"Crit Care"},{"key":"R41-4-20241212","first-page":"45","article-title":"Regenerative effects of Wharton Jelly stem cells-conditioned medium in UVA-Irradiated human dermal fibroblasts","volume":"3","author":"Wirohadidjojo","year":"2016","journal-title":"Malaysian J Med Biol Res"},{"key":"R42-4-20241212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2004.11.002","article-title":"Dual role for TGF-\u00df1 in apoptosis","volume":"16","author":"S\u00e1nchez-A","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"R43-4-20241212","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcyt.2016.12.001","article-title":"Umbilical cord-derived mesenchymal stromal cell-conditioned medium exerts in vitro antiaging effects in human fibroblasts","volume":"19","author":"Li","year":"2017","journal-title":"Cytotherapy"},{"key":"R44-4-20241212","doi-asserted-by":"crossref","first-page":"592454","DOI":"10.1155\/2013\/592454","article-title":"Enhanced healing of diabetic wounds by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media","volume":"2013","author":"Shrestha","year":"2013","journal-title":"Int J Endocrinol"},{"key":"R45-4-20241212","first-page":"141","article-title":"Mesenchymal Stem Cell conditioned Medium Promote the recovery of skin burn wound 41","volume":"132","author":"Padeta","year":"2017","journal-title":"Asian J Anim Vet Adv"},{"key":"R46-4-20241212","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/ijms15010605","article-title":"Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-\u03b2\/SMAD2 and PI3K\/Akt pathways","volume":"15","author":"Jun","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R47-4-20241212","doi-asserted-by":"crossref","first-page":"605","DOI":"10.14202\/vetworld.2016.605-610","article-title":"Human umbilical mesenchymal stem cells conditioned medium promote primary wound healing regeneration","volume":"9","author":"Kusindarta","year":"2016","journal-title":"Vet World"},{"key":"R48-4-20241212","doi-asserted-by":"crossref","first-page":"3738071","DOI":"10.1155\/2017\/3738071","article-title":"A conditioned medium of umbilical cord mesenchymal stem cells overexpressing Wnt7a promotes wound repair and regeneration of hair follicles in mice","volume":"2017","author":"Dong","year":"2017","journal-title":"Stem Cells Int"},{"key":"R49-4-20241212","doi-asserted-by":"crossref","first-page":"e0128078","DOI":"10.1371\/journal.pone.0128078","article-title":"Conditioned media from human umbilical cord blood-derived mesenchymal stem cells inhibits melanogenesis by promoting proteasomal degradation of MITF","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"R50-4-20241212","first-page":"96","article-title":"Conditioned media from human umbilical cord blood-derived mesenchymal stem cells stimulate rejuvenation function in human skin","volume":"16","author":"Kim","year":"2018","journal-title":"Biochem Biophys Rep"},{"key":"R51-4-20241212","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0963689718807410","article-title":"The healing effects of conditioned medium derived from mesenchymal stem cells on radiation-induced skin wounds in rats","volume":"28","author":"Sun","year":"2019","journal-title":"Cell Transplant"},{"key":"R52-4-20241212","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the human development index (2008-2030): A population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"key":"R53-4-20241212","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: a cancer journal for clinicians"},{"key":"R54-4-20241212","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/2231-4040.104709","article-title":"Natural products derived from plants as a source of drugs","volume":"3","author":"Veeresham","year":"2012","journal-title":"J Adv Pharm Technol Res"},{"key":"R55-4-20241212","first-page":"45","article-title":"The effect of Wharton's Jelly mesenchymal stem cells on a squamous cell carcinoma cell line","volume":"4","author":"Elias","year":"2016","journal-title":"Arc Cancer Res"},{"key":"R56-4-20241212","first-page":"134","article-title":"Effect of human Wharton's jelly mesenchymal stem cell secretome on proliferation, apoptosis and drug resistance of lung cancer cells","volume":"10","author":"Hendijani","year":"2015","journal-title":"Res Pharm Sci"},{"key":"R57-4-20241212","first-page":"86","article-title":"Human Wharton's Jelly mesenchymal stem cell secretome display significant antiproliferative effect on K562 leukemia cells","volume":"16","author":"Hendijani","year":"2014","journal-title":"Royan international twin congress, 10th congress on stem cell biology and technology"},{"key":"R58-4-20241212","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.placenta.2017.01.059","article-title":"Amniotic membrane conditioned medium promotes cell death and inhibits proliferation of hepatocarcinoma HepG2 cells","volume":"51","author":"Riedel","year":"2017","journal-title":"Placenta"},{"key":"R59-4-20241212","doi-asserted-by":"crossref","first-page":"57","DOI":"10.18585\/inabj.v6i1.44","article-title":"Conditioned media of human umbilical cord blood mesenchymal stem cell derived secretome induced apoptosis and inhibited growth of hela cells","volume":"6","author":"Sandra","year":"2014","journal-title":"Indones Bio"},{"key":"R60-4-20241212","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10561-019-09781-8","article-title":"An anticancer effect of umbilical cord-derived mesenchymal stem cell secretome on the breast cancer cell line","volume":"20","author":"Mirabdollahi","year":"2019","journal-title":"Cell tissue bank"},{"key":"R61-4-20241212","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.biochi.2013.05.010","article-title":"Mesenchymal stem cell secretome and regenerative therapy after cancer","volume":"95","author":"Zimmerlin","year":"2013","journal-title":"Biochimie"},{"key":"R65-4-20241212","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/stem.1471","article-title":"Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation","volume":"31","author":"Jeong","year":"2013","journal-title":"Stem Cells"},{"key":"R66-4-20241212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.15171\/apb.2017.016","article-title":"Conditioned Medium of Wharton's Jelly Derived Stem Cells Can Enhance the Cartilage Specific Genes Expression by Chondrocytes in Monolayer and Mass Culture Systems","volume":"7","author":"Hassan Famian","year":"2017","journal-title":"Adv Pharm Bull"},{"key":"R67-4-20241212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jnr.23225","article-title":"Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells","volume":"91","author":"Yang","year":"2013","journal-title":"J Neurosci Res"},{"key":"R68-4-20241212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0032-1332325","article-title":"Cardioprotection by cord blood mesenchymal stromal cells through activation of Akt, ERK and STAT3 signaling","volume":"61","author":"Bader","year":"2013","journal-title":"Thorac Cardiovasc Surg"},{"key":"R69-4-20241212","doi-asserted-by":"crossref","first-page":"29994","DOI":"10.1038\/srep29994","article-title":"The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity","volume":"6","author":"Lazzarini","year":"2016","journal-title":"Sci Rep"},{"key":"R70-4-20241212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.5966\/sctm.2014-0253","article-title":"Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis","volume":"4","author":"Danieli","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"R71-4-20241212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jasi.2016.07.005","article-title":"Therapeutic effects of umbilical cord blood derived mesenchymal stem cell-conditioned medium on pulmonary arterial hypertension in rats","volume":"65","author":"Lee","year":"2016","journal-title":"J Anat Soc India"},{"key":"R72-4-20241212","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/nep.13099","article-title":"Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction","volume":"23","author":"Liu","year":"2018","journal-title":"Nephrology (Carlton"},{"key":"R73-4-20241212","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tice.2016.06.010","article-title":"Conditioned medium derived from umbilical cord mesenchymal stem cells regenerates atrophied muscles","volume":"48","author":"Kim","year":"2016","journal-title":"Tissue Cell"},{"key":"R74-4-20241212","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jrr\/rry048","article-title":"The conditioned medium of human mesenchymal stromal cells reduces irradiation-induced damage in cardiac fibroblast cells","volume":"59","author":"Chen","year":"2018","journal-title":"J Radiat Res"},{"key":"R75-4-20241212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-017-0760-6","article-title":"Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4\/NF-\u03baB signaling pathway in vivo and in vitro","volume":"9","author":"Liu","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"R76-4-20241212","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1002\/jcp.29721","article-title":"Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis","volume":"235","author":"Jafarinia","year":"2020","journal-title":"Journal of cellular physiology"},{"key":"R77-4-20241212","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-5956-8-18","article-title":"Proteome analysis of human Wharton's jelly cells during in vitro expansion","volume":"8","author":"Angelucci","year":"2010","journal-title":"Proteome Sci"},{"key":"R78-4-20241212","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1126\/science.316.5830.1422b","article-title":"Adult versus embryonic stem cells: Treatments","volume":"316","author":"Smith","year":"2007","journal-title":"Science"},{"key":"R79-4-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cellbio.19.111301.143037","article-title":"Adult stem cell plasticity: Fact or artifact?","volume":"19","author":"Raff","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R80-4-20241212","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/mt.2016.120","article-title":"Inducible HGF-secreting human umbilical cord blood-derived MSCs produced via TALEN-mediated Genome editing promoted angiogenesis","volume":"24","author":"Chang","year":"2016","journal-title":"Mol Ther"},{"key":"R81-4-20241212","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13287-017-0590-6","article-title":"Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease","volume":"8","author":"de Witte","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"R82-4-20241212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7150\/thno.16154","article-title":"Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: Implications for nanomedicine","volume":"7","author":"Mongui\u00f3-Tortajada","year":"2017","journal-title":"Theranostics"},{"key":"R83-4-20241212","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcyt.2015.10.008","article-title":"The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration","volume":"18","author":"Konala","year":"2016","journal-title":"Cytotherapy"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_1450_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:03:39Z","timestamp":1751497419000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/therapeutic-uses-of-post-partum-tissue-derived-mesenchymal-stromal-cell-secretome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1450_18","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}